Evaluation of a General Practice Based Hepatitis C Virus Screening Intervention

被引:0
作者
Anderson, E. M. [1 ]
Mandeville, R. P. [2 ]
Hutchinson, S. J. [3 ,4 ]
Cameron, S. O. [5 ]
Mills, P. R. [6 ]
Fox, R. [7 ]
Ahmed, S. [1 ]
Taylor, A. [8 ,9 ]
Spence, E. [6 ]
Goldberg, D. J. [4 ]
机构
[1] NHS Greater Glasgow & Clyde, Publ Hlth Protect Unit, Glasgow, Lanark, Scotland
[2] Possilpk Hlth Ctr, Glasgow, Lanark, Scotland
[3] Univ Strathclyde, Dept Stat & Modelling Sci, Glasgow, Lanark, Scotland
[4] Hlth Protect Scotland, Glasgow, Lanark, Scotland
[5] Gartnavel Royal Hosp, W Scotland Specialist Virol Ctr, Glasgow, Lanark, Scotland
[6] Gartnavel Royal Hosp, Gastroenterol Unit, Glasgow, Lanark, Scotland
[7] Gartnavel Royal Hosp, Infect Dis Unit, Brownlee Ctr, Glasgow, Lanark, Scotland
[8] Univ W Scotland, Inst Appl Social & Hlth Res, Paisley, Renfrew, Scotland
[9] Univ W Scotland, Sch Social Sci, Paisley, Renfrew, Scotland
关键词
STRATEGIES; INFECTION;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background In 2003 an estimated 37,500 of Scotland's population was chronically infected with HCV; 44% were undiagnosed former injecting drug users (IDU) - a priority group for antiviral therapy. Aim To evaluate a hepatitis C virus (HCV) screening intervention. Design Outcome measures among two similar General Practice populations in an area of high HCV and drug use prevalence, one of which was exposed to an HCV screening intervention, were compared, Methods Thirty to fifty four year old attendees of the intervention practice were opportunistically offered testing and counselling, where clinically appropriate, (November 2003- April 2004). Outcomes: HCV test uptake, case detection, referral and treatment administration rates. Results Of 584 eligible attendees, 421 (72%) were offered and 117 (28%) accepted testing in the intervention practice; no testing was undertaken in the comparison practice. Prevalences of HCV antibody were 13% (15/117), 75% (3/4) and 91% (10/11) among all tested persons, current IDUs and former IDUs respectively. For 4/15 (27%) evidence of binge drinking following the receipt of their positive result, was available. Of the 11 referred to specialist care because they were HCV RNA positive, nine attended at least one appointment. Two received treatment: one had achieved a sustained viral response as of February 2008. Conclusion While non targeted HCV screening in the general practice setting can detect infected former IDU, the low diagnostic yield among non IDUs limited the effectiveness of the intervention. A more targeted approach for identifying former IDUs is recommended. Additionally, the low uptake of treatment among chronically infected persons four years after diagnosis demonstrates the difficulties in clinically managing such individuals. Strategies, including support for those with a history of problem alcohol use, to improve treatment uptake are required.
引用
收藏
页码:3 / 7
页数:5
相关论文
共 50 条
  • [21] Hepatitis C Virus Screening and Management of Seroconversions in Hemodialysis Facilities
    Mbaeyi, Chukwuma
    Thompson, Nicola D.
    SEMINARS IN DIALYSIS, 2013, 26 (04) : 439 - 446
  • [22] Hepatitis C Virus Screening and Emergency Department Length of Stay
    White, Douglas A. E.
    Anderson, Erik S.
    Pfeil, Sarah K.
    Deering, Laura J.
    Todorovic, Tamara
    Trivedi, Tarak K.
    PLOS ONE, 2016, 11 (10):
  • [23] Universal Screening for Hepatitis C: An Important Step in Virus Elimination
    Chhatwal, Jagpreet
    Sussman, Norman L.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2019, 17 (05) : 835 - 837
  • [24] Hepatitis-C Virus Prevalence in District Shangla and Evaluation of Screening Tests for Anti-HCV
    Khan, Jehangir
    Rasheedullah
    Khan, Bakht Tarin
    Ahmad, Ayaz
    Salman, Muhammad
    Khan, Khalid
    PAKISTAN JOURNAL OF ZOOLOGY, 2018, 50 (04) : 1299 - 1305
  • [25] Hepatitis C in two general practices in Flanders, Belgium: is there a need to reconsider current screening recommendations?
    Botterman, Ruth
    Verhelst, Xavier
    Buffel, Veerle
    Derese, Anselme
    Van der Paelt, Thomas
    De Volder, Garence
    Van Vlierberghe, Hans
    Boeckxstaens, Pauline
    ACTA CLINICA BELGICA, 2021, 76 (06) : 462 - 469
  • [26] Screening for hepatitis C in a general adult population in a low-prevalence area: the TromsO study
    Kileng, H.
    Gutteberg, T.
    Goll, R.
    Paulssen, E. J.
    BMC INFECTIOUS DISEASES, 2019, 19 (1)
  • [27] The pharmacokinetic evaluation of boceprevir for treatment of Hepatitis C virus
    Shankar, Hari
    Bichoupan, Kian
    Dieterich, Douglas T.
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2013, 9 (12) : 1647 - 1657
  • [28] Therapeutic Intervention of Serine Protease Inhibitors against Hepatitis C Virus
    Kamal, Shagufta
    Shahzad, Asif
    Rehman, Kanwal
    Tariq, Komal
    Akash, Muhammad Sajid Hamid
    Imran, Muhammad
    Assiri, Mohammed Ali
    CURRENT MEDICINAL CHEMISTRY, 2024, 31 (15) : 2052 - 2072
  • [29] Evaluation of the efficiency of dried blood spot-based measurement of hepatitis B and hepatitis C virus seromarkers
    Yamamoto, Chikako
    Nagashima, Shintaro
    Isomura, Mitsuo
    Ko, Ko
    Chuon, Channarena
    Akita, Tomoyuki
    Katayama, Keiko
    Woodring, Joseph
    Hossain, Md. Shafiqul
    Takahashi, Kazuaki
    Tanaka, Junko
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [30] Updated CDC Recommendations for Universal Hepatitis C Virus Screening Among Adults and Pregnant Women Implications for Clinical Practice
    Havens, Peter L.
    Anderson, Jean R.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2020, 323 (22): : 2258 - 2259